Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.
about
Role of Biomarkers in the Development of PARP InhibitorsPredictive biomarkers for triple negative breast cancer treated with platinum-based chemotherapy.Multi-gene fluorescence in situ hybridization to detect cell cycle gene copy number aberrations in young breast cancer patients.Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapyAssessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples.High levels of genomic aberrations in serous ovarian cancers are associated with better survival.Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.A novel role for the mono-ADP-ribosyltransferase PARP14/ARTD8 in promoting homologous recombination and protecting against replication stressCompanion diagnostics: changing patient managementRouting of Biomolecules and Transgenes' Vectors in Nuclei of OocytesIdentification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions: a validation study.A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancerTherapeutic applications of PARP inhibitors: anticancer therapy and beyondComprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.Proteomics insights into DNA damage response and translating this knowledge to clinical strategies.The detection and implication of genome instability in cancerGenetic Dissection of Cancer Development, Therapy Response, and Resistance in Mouse Models of Breast Cancer.Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study.Prediction of therapy response in ovarian cancer: Where are we now?Genetic variation in the DNA repair pathway as a potential determinant of response to platinum-based chemotherapy in breast cancer.Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2-like male breast cancer.Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms.Effects of TPX2 gene on radiotherapy sensitization in breast cancer stem cells.The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting.Platform comparisons for identification of breast cancers with a BRCA-like copy number profile.
P2860
Q26753159-01522001-A63B-4EDF-B1D3-F49BAFD2077CQ33441772-6DF736E6-535D-4DAA-88BA-FE338CCF87F3Q33728390-19D73507-1595-45A5-A820-FD5BECFF3816Q33827045-EF1AC4E3-8B53-421E-A00D-79ECD0C154BFQ33877435-B7B80F9A-0764-4C56-AE24-A332FB39EDC8Q34571142-434A3A8D-1E2E-4557-823A-E9DE4EB7B56CQ34663583-758F6882-CE0F-49F4-926A-1A117BCF411EQ35237048-548E50C6-4A6D-41F5-A3C8-8D7B2217F313Q35818050-230D5B54-4319-4C8F-87A5-158FCFA66D97Q36161007-6C3CFFB6-7F71-4108-9A72-0C11B9E9BE26Q36166929-71606D06-8B22-4FE6-BFFA-CBDF6753BCCBQ36181844-0F60293D-B252-488C-BDAF-1890BAB24B57Q36853236-711C325A-62B8-4BF4-A79D-006C0EB101A5Q37362685-2AA289C2-50D3-4DC3-B528-7F1C9BAC480DQ37665387-52990A55-3015-4E73-A796-70997277CB91Q37676851-8CD29A44-F67F-4A7F-9BDE-CB2231575724Q38103187-0C304606-CEAE-4D77-ADF5-2E97F908BAE6Q38798405-ED8E0E73-2C63-49A6-B8D4-5DA28D500C6CQ39038900-5E854CE9-E649-4C63-9F68-EBE7047639C1Q39263260-7EEF0961-A53C-4C94-90D6-984B74D78C8AQ39428059-2ADE3D6C-7957-4F3C-9B4B-41F180E89972Q40556065-F354554F-6750-4F71-906E-5EDEFA8AA0E8Q41136538-E2403CAB-3FE9-4C5F-A870-DCD5185C07BAQ41142259-0409BEC7-B9CB-4274-B8C1-E2A3A9334F28Q41542872-3B398263-2D33-4542-A066-6D9A109A52E9Q50997123-F17DA98B-71D4-4972-A6ED-9A29925A12D4
P2860
Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Genomic instability in breast ...... linical predictive biomarkers.
@en
Genomic instability in breast ...... linical predictive biomarkers.
@nl
type
label
Genomic instability in breast ...... linical predictive biomarkers.
@en
Genomic instability in breast ...... linical predictive biomarkers.
@nl
prefLabel
Genomic instability in breast ...... linical predictive biomarkers.
@en
Genomic instability in breast ...... linical predictive biomarkers.
@nl
P2093
P2860
P1476
Genomic instability in breast ...... linical predictive biomarkers.
@en
P2093
Jos Jonkers
Marieke A Vollebergh
Sabine C Linn
P2860
P2888
P304
P356
10.1007/S00018-011-0809-0
P577
2011-09-16T00:00:00Z